Kinevant Sciences
Cynthia Scott has more than 15 years of regulatory experience working on biologics and small molecules, in the areas of diabetes, oncology, infectious diseases, and rare diseases. Prior to joining Kinevant, Cynthia served as a regulatory consultant for over 10 years where she led cross-functional teams toward global product development goals, providing regulatory strategy and team leadership, ranging from early to late phase development.
Cynthia earned a BS from Eastern Nazarene College and an MS in Drug Regulatory Affairs and Health Policy from Massachusetts College of Pharmacy and Health Sciences.
This person is not in any teams
This person is not in any offices
Kinevant Sciences
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.